September 9th, 2021


AlphaThera has announced a distribution agreement with Funakoshi Co., Ltd. for distribution of AlphaThera’s oYo-Link® Antibody labeling products throughout Japan. Funakoshi Co., Ltd. is a leading distributor of innovative reagents and research instruments throughout Japan and internationally, serving an extensive network of universities and companies.


Since launching its oYo-Link antibody labeling products, AlphaThera has seen growing interest from customers in Japan. As AlphaThera continues its rapid global expansion, this distribution agreement will help AlphaThera effectively deliver the oYo-Link Antibody labeling technology to new researchers.


AlphaThera looks forward to collaborating with the Funakoshi team to reach this market and offer an innovative tool for scientists. The oYo-Link Antibody labeling products will soon be available to researchers in Japan through Funakoshi.


About Funakoshi Co. Ltd:


Funakoshi Co., Ltd. is a leading distributor of research reagents and instruments for the life science fields throughout Japan and other regions. Their corporate mission is to provide high quality products to a broad range of customers in their domestic and international network.


Visit their website for more information: